Home
Science News
Academia
Campus Konnect
Researcher Spotlight
Faculty Konnect
Industry
Pharma & Biopharma
Vaccine and Technology
Industry Experts
Regulatory
Startup
Funding & Grants
Incubation Center
Startup Konnect
Career
Career opportunities
Award, fellowship & grant
Events
Career Konnect
Mentor Konnect
Storify India
Search
BioPatrika
BioPatrika
Go
Search
Home
Science News
Academia
Campus Konnect
Researcher Spotlight
Faculty Konnect
Industry
Pharma & Biopharma
Vaccine and Technology
Industry Experts
Regulatory
Startup
Funding & Grants
Incubation Center
Startup Konnect
Career
Career opportunities
Award, fellowship & grant
Events
Career Konnect
Mentor Konnect
Storify India
Tag Results:
author interview
Academia
Award, fellowship & grant
Business and Market Strategy
Campus Konnect
Career
Career Konnect
Researcher Spotlight
Malarial Parasites Overcome Unusual ‘hurdles’ to Synthesize Proteins
Researcher Spotlight
Molecular traffic and behaviour of biomolecules
Researcher Spotlight
CLASP: An on-demand sensor for lactate monitoring
Researcher Spotlight
Prion-like p53 amyloids and their link to cancer pathogenesis
Researcher Spotlight
Gut pathogens deploy anti-apoptotic pathway to maintain infectious foothold in their host
Researcher Spotlight
Plant cyclotides protect against β-amyloid toxicity in transgenic Caenorhabditis elegans
Researcher Spotlight
A Talk on Nanotheranostic System for Targeted Breast Cancer Therapy developed by IISER-K
Researcher Spotlight
Mechanobiology: Mechanical force-induced selective cancer cell killing
Researcher Spotlight
Nano medicine therapeutics for targeted Gene Silencing in Ovarian cancer
Load more
Narayana Health Performs India’s First Pulsed Field Ablation for Atrial Fibrillation
June 6, 2026
Gold Nanoparticles Enable Electrophoresis-Free SNP Genotyping and PCR Detection
June 6, 2026
Applications Open for Prime Minister Research Chair (PMRC) Scheme 2026
June 5, 2026
Artificial Heart Pumps Help Save Three Teenagers Before Heart Transplants at Narayana Health
June 5, 2026
Lupin Receives U.S. FDA Approval for Interchangeable Ranibizumab Biosimilar Ranluspec
June 5, 2026